OneSource Specialty Pharma Limited, formerly known as Stelis Biopharma Limited, is India’s first specialty pharma pure-play Contract Development and Manufacturing Organization (CDMO) business. By integrating Stelis’ Biologics CDMO, SteriScience's Complex Injectables, and Strides' Soft Gelatin businesses, it is positioned to deliver exceptional services to its customers. 

Following the NCLT process and listing, OneSource Specialty Pharma will operate state-of-the-art facilities in Bengaluru, India, all approved by major regulatory bodies, including the USFDA and EU authorities. Its comprehensive solutions span across platforms and therapeutic modalities, including Biologics, Drug-device combinations, Complex Injectables, and Oral Technologies. Committed to innovation and excellence, it supports global partners in delivering life-saving products efficiently.

Business area of the company

OneSource Specialty Pharma is a multimodal specialty pharma CDMO with end-to-end capabilities across technology platforms and therapeutic modalities.